GenomOncology (GO), a leader in precision medicine reporting solutions, today announced a strategic partnership with Oregon Health & Science University's (OHSU) Knight Diagnostics Lab (KDL) to enhance ...

Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...

Own the Bone® program and RevelAi Health announces a collaboration to build an AI-powered bone health navigator that helps ...

The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...

How AI, robotics, and modular design are transforming single-cell and spatial biology into scalable, precision-driven engines of discovery.

Improving equitable access to genomics-based clinical trials remains a critical priority in cancer care, according to Dr.

Solventum MEDITECH Expanse Accelerator partnership integrates AI to streamline clinical documentation and reduce clinician administrative burden.

Jo Varshney, PhD, DVM, discusses how VeriSIM Life’s innovative approach leverages artificial intelligence and multispecies ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

A biostatistician in New Jersey who consulted for pharmaceutical companies used insider information to buy stock before positive drug trial results were announced, netting nearly $500,000 in profits, ...